Allergic Rhinitis Pharmacology

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/91

flashcard set

Earn XP

Description and Tags

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

92 Terms

1
New cards

which drug classes are used in AR?

intranasal corticosteroids, antihistamines, decongestants, cromolyn, ipratropium, leukotriene receptor antagonists

2
New cards

MOA of INCS in allergic rhinitis

reduce antigen-induced hyperresponsiveness of the nasal mucosa to subsequent challenge by antigen and histamine release; target early steps in the inflammatory process, effectively blocking the allergic cascade

3
New cards

what do INCS have an effect on?

congestion, rhinorrhea, sneezing, nasal itching, ocular symptoms

4
New cards

onset of INCS

ranges from 3-5 hours to 36 hours after first dose

5
New cards

when is efficacy reached for INCS

after 1 week of continuous use (peak response may take up to 2-3 weeks)

6
New cards

T/F: all INCS preparations are comparable in efficacy

true

7
New cards

ADRs of INCS

HA, dryness, burning, stinging, blood-stinged secretions, epistaxis

8
New cards

who should avoid using INCS?

patients with nasal septum ulcers, recent nasal surgery, or trauma

9
New cards

what is long-term use of INCS linked to?

changes in vision, glaucoma, and cataract formation

10
New cards

T/F: HPA suppression is unlikely with INCS (patients with HIV may have more systemic absorption)

true

11
New cards

T/F: fluticasone, mometasone, triamcinolone appear to have no effect on growth suppression

true

12
New cards

which INCS are OTC

budesonide (Rhinocort Allergy 12+), Fluticasone propionate (Flonase ALlergy Relief 4+), fluticasone furoate (Flonase Sensimist 2+), and triamcinolone (Nasacort Allergy 24 hour 2+)

13
New cards

which INCS are Rx

beclomethasone (Qnasl, Qnasl Childrens 4+), flunisolide (generics 6+), fluticasone propionate (Xhance), mometasone (Nasonex 2+), ciclesonide (Omnaris 12+)

14
New cards

MOA of antihistamines

competitively antagonizes histamine-1 receptors to prevent receptor activation

15
New cards

which oral antihistamine generation is lipophilic, crosses BBB, anticholinergic effects and excessive sedation

1st generation

16
New cards

which oral antihistamine generation is highly selective for H1 receptors and has limited penetration into CNS

2nd generation

17
New cards

ADRs of 1st generation oral antihistamines

dry eyes, dry mouth, urinary retention, constipation, changes in appetite

18
New cards

T/F: 2nd generation OAH have more favorable SE profile but can still cause drowsiness

true

19
New cards

which generation OAH is not recommended for routine use in allergic rhinitis?

1st generation

20
New cards

caution use of 1st generation OAH in which patients?

elderly patients, use of other CNS depressants or anticholinergic agents, urinary retention issues/BPH, slowed GI motility, narrow-angle glaucoma, combination products

21
New cards

which medications are ethanolamines (1st gen OAH)

diphenhydramine, doxylamine

22
New cards

which medications are alkylamines (1st gen)

brompheniramine, chlorpheniramine

23
New cards

which drugs are piperazines (2nd generation)

cetirizine, levocetirizine

24
New cards

which drugs are piperidines (2nd generation)

fexofenadine, loratadine, and desloratadine

25
New cards

properties of ethanolamines

highly sedating, strong anticholinergic effects

26
New cards

properties of alkylamines

moderately sedating, strong anticholinergic effects, higher risk of paradoxical CNS stimulation vs. other classes

27
New cards

properties of piperazines

minimally to moderately sedating

28
New cards

properties of piperidines

nonsedating

29
New cards

PK considerations for 1st generation OAH

onset: 15 minutes - 1 hour

duration: 4-6 hours

30
New cards

PK considerations for 2nd generation OAH

onset: 1-3 hours

duration: > 24 hours

31
New cards

what do oral antihistamines have an effect on

minimal effect on congestion, rhinorrhea, sneezing, nasal itching, ocular symptoms

32
New cards

which OAH is prescription only

desloratadine (Clarinex)

33
New cards

brand of cetirizine

Zyrtec

34
New cards

brand of levocetirizine

Xyzal

35
New cards

brand of loratadine

Claritin

36
New cards

brand of fexofenadine

Allegra

37
New cards

PK considerations for INAH

rapid onset of action 15-30 minutes

38
New cards

what is the advantage of using INAH vs OAH?

more targeted delivery which allows for increased dosage to nasal tissue while limiting systemic effects

39
New cards

what do intranasal antihistamines have an effect on

congestion, rhinorrhea, sneezing, nasal itching

40
New cards

ADRs of INAH

bitter taste, epistaxis, HA, somnolence and nasal burning (taste and BID dosing may limit adherence)

41
New cards

T/F: INAH are equal or superior to OAH

true

42
New cards

which product is superior for nasal congestion, INAH or OAH

INAH

43
New cards

which INAH is available OTC

azelastine

44
New cards

which medications are INAH

azelastine, olopatadine, azelastine/fluticasone, olopatadine/mometasone

45
New cards

bran do azelastine/fluticasone

Dymista

46
New cards

brand of olopatadine/mometasone

Ryaltris

47
New cards

when to use ophthalmic antihistamines

relieves allergic conjunctivitis

48
New cards

T/F: ophthalmic antihistamines are appropriate as monotherapy or in combination with oral agents

true

49
New cards

ADRs of ophthalmic antihistamines

HA, blurred vision, burning/stinging of the eyes, discomfort, bitter taste, pharyngitis

50
New cards

what do ophthalmic antihistamines have an effect on?

ocular symptoms

51
New cards

which medications are ophthalmic antihistamines?

ketotifen, azelastine, olopatadine, alcaftdadine, epinastine, bepotastine, cetirizine

52
New cards

which ophthalmic antihistamines are available OTC

ketotifen, olopatadine, alcaftdadine

53
New cards

brand of ketotifen

Alaway, Zaditor

54
New cards

brand of olopatadine

Pataday, Pazeo

55
New cards

brand of alcaftdadine

Lastacaft

56
New cards

brand of bepotastine

Bepreve

57
New cards

brand of ophthalmic cetirizine

Zerviate

58
New cards

MOA of decongestants

sympathomimetic agents that target adrenergic receptors in the nasal mucosa to produce vasoconstriction

59
New cards

how can decongestants help allergic rhinitis?

reduce swollen nasal mucosa and improve ventilation (systemic and topical options)

60
New cards

PK of topical decongestants

rapid onset of action (within 10 minutes)

61
New cards

which medication should not be used for more than 3 days?

intranasal decongestants

62
New cards

ADRs of topical decongestants

sneezing, burning, stinging, drying of nasal mucosa

63
New cards

which medications are topical decongestants?

phenylephrine, naphazoline, oxymetazoline

64
New cards

T/F: topical decongestants are available OTC

true

65
New cards

which nasal decongestant does not have safety/efficacy data in children?

naphazoline

66
New cards

T/F: oral decongests are only used as monotherapy and are not in combination products

false

67
New cards

ADRs of oral decongestants

increases in BP (avoid use with MAOIs), CNS stimulation, urinary retention

68
New cards

which medications are oral decongestants?

pseudoephedrine and phenylephrine

69
New cards

brand of cromolyn

NasalCrom

70
New cards

when is cromolyn useful

useful for treating and preventing sinus symptoms (runny nose, stuffy nose, sneezing, itching)

71
New cards

MOA of cromolyn

mast cell stabilizer

72
New cards

ADRs of cromolyn

sneezing and nasal irritation

73
New cards

dosing for cromolyn

1 spray in each nostril 3-4 times daily (up to 6 times daily) in patients 2+

74
New cards

PK considerations for cromolyn

slow onset of action, response to treatment can take up to 1-2 weeks

75
New cards

what does ipratropium treat when used intranasally?

rhinorrhea

76
New cards

MOA of ipratropium

anticholinergic

77
New cards

ADRs of intranasal ipratropium

HA, nosebleeds, and nasal dryness

78
New cards

caution use of ipratropium in which patients?

narrow-angle glaucoma, myasthenia gravis, and bladder neck obstructions/BPH

79
New cards

dosing for intranasal ipratropium

2 sprays 2-4 times daily for patients 5 years and up

80
New cards

PK considerations for intranasal ipratropium

quick onset of action (within 15 minutes)

81
New cards

what can montelukast treat

symptoms of perennial and seasonal allergic rhinitis

82
New cards

dosing for montelukast

>/= 15 years old: 10 mg PO daily in the evening

children 6 years - 14 years: 5 mg PO daily

children 6 months-5 years: 4 mg daily (chewable tab or granule packet)

83
New cards

how long does it take to see the full effect of montelukast

~ 1 month

84
New cards

which medication is a monoclonal antibody for AR?

omalizumab (Xolair)

85
New cards

MOA of omalizumab

binds circulating IgE to prevent binding to mast cells

86
New cards

what is omalizumab approved for?

allergic asthma

87
New cards

what are the risks associated with omalizumab?

anaphylaxis, malignancy, acute asthma attacks, serum sickness

88
New cards

what is the last-line therapy for AR and typically requires specialist input prior to receiving?

omalizumab

89
New cards

describe immunotherapy in AR

gradual process of injecting increasing doses of allergens to induce tolerance, reserved for significant symptoms despite pharmacotherapy (expensive and considerable time commitment)

90
New cards

LTRA role in symptom management?

minimal resolution of congestion, rhinorrhea, sneezing, and nasal itching

91
New cards

what does cromolyn have an effect on?

congestion, rhinorrhea, sneezing, nasal itching

92
New cards

what does intranasal ipratropium have an effect on?

rhinorrhea and minimal effect on sneezing and nasal itching